Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Clinical trial NCT06817525 · RECRUITING

Trial details

NCT number: NCT06817525
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2024-11-06
Primary completion: 2026-05-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.